Opportunity Information: Apply for PAR 10 180

  • The National Institutes of Health in the environment health income security and social services sector is offering a public funding opportunity titled "Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113 Environmental Health 93.846 Arthritis, Musculoskeletal and Skin Diseases Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.856 Microbiology and Infectious Diseases Research 93.859 Biomedical Research and Research Training 93.865 Child Health and Human Development Extramural Research 93.867 Vision Research.
  • This funding opportunity was created on Mar 16, 2011 and posted on Apr 29, 2010.
  • Applicants must submit their applications by Mar 16, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $6,000,000.00 to eligible and selected applicants.
  • Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Public and State controlled institutions of higher education Independent school districts Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments State governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) Private institutions of higher education Special district governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 10 180

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01) opportunity (Funding Opportunity Number PAR 10 180) is a National Institutes of Health (NIH) funding program aimed at pushing forward practical medical treatments for harmful chemical exposures. The central goal is to develop new and improved therapeutics that could be used when toxic chemicals are released intentionally (for example, in a terrorist attack) or unintentionally (for example, through industrial accidents during production, storage, or transportation). The FOA makes clear that the program is not limited to classic military chemical warfare agents; it also explicitly targets toxic industrial chemicals and certain pesticides. Examples called out in the announcement include nerve agents such as sarin and VX, and other high risk chemicals such as cyanide, chlorine, parathion, and sodium fluoroacetate. In other words, the focus is on medical countermeasures that can realistically reduce illness and death after exposure to a wide range of dangerous chemicals that pose public health and national security risks.

From a research and development standpoint, the scope is intentionally translational, meaning it is meant to move beyond basic science and toward products that could plausibly be used in real emergencies. Projects can start as early as target identification and candidate discovery, then move through candidate characterization and optimization, and continue into in vivo efficacy testing. For projects that are sufficiently advanced and appropriate for that stage, the FOA also allows progression toward Investigational New Drug (IND) enabling work, IND submission, and even Phase 1 clinical trials. A defining requirement is that each funded project must be structured around clear milestones with discrete go or no go decision points. That milestone driven design is meant to enforce disciplined development planning, where teams can demonstrate progress, make evidence based decisions, and stop or redirect approaches that are not meeting performance expectations.

The funding mechanism is a cooperative agreement (U01), not a standard research project grant. Practically, that signals a more hands on partnership model with NIH, where the agency typically expects meaningful scientific and programmatic involvement during the project period compared with an R01. The FOA also notes that it runs in parallel with a separate opportunity of identical scientific scope for larger, center based programs, the CounterACT Research Centers of Excellence (U54), listed as PAR 10 181. The U01 track is therefore positioned for individual cooperative research projects, while the U54 track supports broader center structures, but both are aligned around the same overarching mission of developing medical countermeasures against chemical threats.

In terms of funding levels, the participating NIH Institutes planned to commit an average of about 6 million dollars per year during Fiscal Years 2011, 2012, and 2013 for new awards and competing renewals under this program. The announcement emphasizes that award size and duration are expected to vary widely because projects may sit at different stages of the translational pipeline and may require different kinds of resources (for example, medicinal chemistry optimization versus animal efficacy studies versus early clinical activities). The final number of awards and total dollars awarded would ultimately depend on the volume of applications received, their scientific and technical quality, their proposed timelines, and their requested budgets.

Eligibility is broad and includes many categories of applicants across academia, government, nonprofit, and industry. Eligible applicants listed include public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non 501(c)(3) organizations), for profit organizations (other than small businesses), small businesses, state and local governments (including counties, cities, townships, special districts, and independent school districts), public housing authorities, and multiple types of Tribal entities. The FOA also explicitly includes a range of special designations and community anchored institutions and organizations, such as Historically Black Colleges and Universities (HBCUs), Hispanic serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, faith based or community based organizations, regional organizations, and U.S. territories or possessions. There is no cost sharing or matching requirement indicated.

Key administrative details in the source information include a posted date of April 29, 2010, with NIH as the sponsoring agency. The activity spans multiple NIH related program areas as reflected by the CFDA numbers provided (including environmental health and several biomedical research domains). The listing includes an Additional Information link pointing to the NIH grants guide page for PAR 10 180, and provides NIH Office of Extramural Research (OER) webmaster contacts for applicants who have technical difficulty accessing or linking to the full announcement.

Frequently Asked Questions (FAQs)

What is the Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01) opportunity?

It is an NIH funding opportunity (Funding Opportunity Number PAR 10 180) focused on advancing practical medical treatments (therapeutics) for harmful chemical exposures. The intent is to move candidate countermeasures toward real-world use during emergencies involving toxic chemical releases.

What is the main goal of this funding opportunity?

The central goal is to develop new and improved therapeutics that could reduce illness and death after exposure to dangerous chemicals, whether those releases are intentional (for example, terrorism) or unintentional (for example, industrial accidents during production, storage, or transportation).

Is the program limited to military chemical warfare agents?

No. The opportunity is not limited to classic military chemical warfare agents. It explicitly includes toxic industrial chemicals and certain pesticides, reflecting both public health and national security concerns.

What chemical threats are specifically mentioned as examples?

Examples called out include nerve agents such as sarin and VX, and other high-risk chemicals such as cyanide, chlorine, parathion, and sodium fluoroacetate.

What types of research does the FOA emphasize?

The scope is translational, meaning it is intended to move beyond basic science toward products that could plausibly be used in real emergencies. The funding is meant to support development steps that make a therapeutic more practical and deployable.

At what stages of development can a project start?

Projects may begin as early as target identification and candidate discovery, and can progress through candidate characterization and optimization and into in vivo efficacy testing.

Does the FOA allow work related to IND and clinical trials?

Yes. For projects that are sufficiently advanced and appropriate for that stage, the FOA allows progression toward IND-enabling work, IND submission, and even Phase 1 clinical trials.

What is the required project structure or management approach?

Each funded project must be built around clear milestones with discrete go/no-go decision points. This milestone-driven structure is intended to support disciplined development planning, evidence-based decisions, and stopping or redirecting approaches that are not meeting expectations.

What does it mean that this is a U01 cooperative agreement?

U01 is a cooperative agreement rather than a standard research project grant. This signals a more hands-on partnership model with NIH, where meaningful scientific and programmatic involvement by NIH is typically expected during the project period compared with an R01.

How does this U01 opportunity relate to the CounterACT Research Centers of Excellence (U54)?

The FOA notes a parallel opportunity of identical scientific scope for larger, center-based programs: the CounterACT Research Centers of Excellence (U54), listed as PAR 10 181. The U01 track supports individual cooperative research projects, while the U54 track supports broader center structures; both align with the same mission of developing medical countermeasures against chemical threats.

How much funding is planned under this program?

Participating NIH Institutes planned to commit an average of about $6 million per year during Fiscal Years 2011, 2012, and 2013 for new awards and competing renewals under the program.

Are award sizes and project durations fixed?

No. The announcement emphasizes that award size and duration are expected to vary widely because projects can be at different stages of the translational pipeline and can require different resources (for example, medicinal chemistry optimization, animal efficacy studies, or early clinical activities).

How is the final number of awards determined?

The final number of awards and total dollars awarded depend on factors such as the volume of applications received, the scientific and technical quality of those applications, proposed timelines, and the requested budgets.

Who is eligible to apply?

Eligibility is broad and includes many applicant categories across academia, government, nonprofit, and industry. Eligible applicants include public and private institutions of higher education; nonprofits (including 501(c)(3) and certain non-501(c)(3) organizations); for-profit organizations (other than small businesses); small businesses; state and local governments (including counties, cities, townships, special districts, and independent school districts); public housing authorities; and multiple types of Tribal entities.

Are community-anchored and special-designation institutions included in eligibility?

Yes. The FOA explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.

Is cost sharing or matching required?

No cost sharing or matching requirement is indicated in the provided information.

When was this opportunity posted, and who is the sponsoring agency?

The posted date is April 29, 2010. The sponsoring agency is the National Institutes of Health (NIH).

Are there any administrative references or program identifiers mentioned?

Yes. The listing references multiple NIH-related program areas as reflected by the CFDA numbers provided (including environmental health and several biomedical research domains).

Where can applicants find the official full announcement?

The source information mentions an Additional Information link pointing to the NIH Grants Guide page for PAR 10 180.

Who should applicants contact if they have technical difficulty accessing the announcement?

The listing provides NIH Office of Extramural Research (OER) webmaster contacts for applicants who have technical difficulty accessing or linking to the full announcement.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Environment Health Income Security and Social Services

Next opportunity: Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)

Previous opportunity: Economic Strengthening for Households Affected by AIDS

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 10 180

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 10 180) also looked into and applied for these:

Funding Opportunity
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54) Apply for PAR 10 181

Funding Number: PAR 10 181
Agency: National Institutes of Health
Category: Environment Health Income Security and Social Services
Funding Amount: Case Dependent
Developmental Pharmacology (R01) Apply for PAR 11 057

Funding Number: PAR 11 057
Agency: National Institutes of Health
Category: Environment Health Income Security and Social Services
Funding Amount: $499,999
Developmental Pharmacology (R03) Apply for PAR 11 058

Funding Number: PAR 11 058
Agency: National Institutes of Health
Category: Environment Health Income Security and Social Services
Funding Amount: $50,000
Developmental Pharmacology (R21) Apply for PAR 11 059

Funding Number: PAR 11 059
Agency: National Institutes of Health
Category: Environment Health Income Security and Social Services
Funding Amount: $200,000
Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01) Apply for PAR 11 155

Funding Number: PAR 11 155
Agency: National Institutes of Health
Category: Environment Health Income Security and Social Services
Funding Amount: Case Dependent
Autism Centers of Excellence Centers (P50) Apply for RFA HD 12 195

Funding Number: RFA HD 12 195
Agency: National Institutes of Health
Category: Environment Health Income Security and Social Services
Funding Amount: $1,500,000
Autism Centers of Excellence Networks (R01) Apply for RFA HD 12 196

Funding Number: RFA HD 12 196
Agency: National Institutes of Health
Category: Environment Health Income Security and Social Services
Funding Amount: $2,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 180", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.